Impact of (recurrent) bacterial vaginosis on quality of life and the need for accessible alternative treatments
Abstract Background Bacterial vaginosis (BV) is one of the most common vaginal dysbiosis in women aged 15–44 years old. Methods We administered a cross-sectional, single timepoint survey to women ages 18 years or older and who have had bacterial vaginosis (BV). Women completed an anonymous online su...
Main Authors: | Karen Chow, Darcy Wooten, Sindhuja Annepally, Leah Burke, Rina Edi, Sheldon R. Morris |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-03-01
|
Series: | BMC Women's Health |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12905-023-02236-z |
Similar Items
-
Comparsion of the Effect of Lactobacillus Acidophilus Suppository and Metronidazol Vaginal Tablet on Bacterial Vaginosis
by: Asghar Mohamad Poorasl, et al.
Published: (2011-09-01) -
Comparsion of the effect of Lactobacillus Acidophilus Suppository and Metronidazol Vaginal Tablet on Bacterial Vaginosis
by: Hamideh Jafarzadeh, et al.
Published: (2011-09-01) -
Novel insights in bacterial vaginosis etiology through genomic approaches
by: MARCELLE O. ALMEIDA, et al.
Published: (2021-03-01) -
A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis
by: Jane R. Schwebke, et al.
Published: (2021-04-01) -
Inhibitory effect of Lactobacillus rhamnosus on pathogenic bacteria isolated from women with bacterial vaginosis
by: Gita Eslami, et al.
Published: (2014-06-01)